Scientists at the National Eye Institute have found the first direct evidence that Stargardt-related ABCA4 gene mutations affect the retinal pigment epithelium (RPE).

The discovery points to a new understanding of the progression of this rare inherited blinding disease and suggests a therapeutic strategy. The research team used a new stem cell-based model made from skin cells, according to the study published in Stem Cell Reports.